ADVIA Centaur® HCV assay
FDA premarket approval P030056/S009 · decided 2016-09-09
Approval details
- PMA number
- P030056
- Supplement
- S009
- Supplement type
- Normal 180 Day Track
- Supplement reason
- Labeling Change - Indications/instructions/shelf life/tradename
- Trade name
- ADVIA Centaur® HCV assay
- Generic name
- Assay, enzyme linked immunosorbent, hepatitis c virus
- Applicant
- Siemens Healthcare Diagnostics
- Date received
- 2015-05-01
- Decision date
- 2016-09-09
- Days to decision
- 497 days
- Decision code
- APPR
- Product code
- MZO
- Advisory committee
- Microbiology
- Expedited review
- No
- Location
- East Walpole, MA
- Statement
- Approval for the migration of the ADVIA Centaur® HCV (aHCV) to the ADVIA Centaur® XPT system.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.